Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Usc Keck School Of Medicine
2011 Zonal Avenue, Hmr 205
Los Angeles, CA 90089Phone+1 818-426-9595Fax+1 323-442-3049
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 1984 - 1985
Stanford University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1985 - 2025
Publications & Presentations
PubMed
- 457 citationsCharacterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear CellsMelissa G. Lechner, Daniel J. Liebertz, Alan L. Epstein
Journal of Immunology. 2010-08-15 - 105 citationsMHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In VitroTrevor E. Angell, Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, Alan L. Epstein
Clinical Cancer Research. 2014-12-01 - 167 citationsFunctional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a divers...Melissa G. Lechner, Carolina Megiel, Sarah M. Russell, Brigid Bingham, N. Arger
Journal of Translational Medicine. 2011-06-09
Press Mentions
Congress of Clinical Rheumatology Reloaded: West Follows East with Fresh Topics, SpeakersAugust 27th, 2021
Grant Support
- Monoclonal Antibodies Against T-Regulatory CellsNational Cancer Institute2004–2005
- TNT Imaging To Monitor The Efficacy Of Cancer TherapyNational Cancer Institute2000–2002
- Immunotherapy Of Lymphomas With Lym-1 And Lym-2National Cancer Institute1994
- Immunotherapy Of Human Lymphomas With Lym-1 And Lym-2National Cancer Institute1992–1993
- Tumor Necrosis Treatment Of Human CancerNational Cancer Institute1991–1993
- Immunotherapy Of Human Lymphomas W/Lym-1 &Lym-2National Cancer Institute1988–1990
- Development And Characterization Of Myeloma Cell LinesNational Cancer Institute1985–1987
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
